Condition: Lafora Disease · Sponsor: Berge Minassian
This study will test the safety and efficacy of multiple doses of ION283 administered as intrathecal (IT) injections by lumbar puncture (LP). All subjects will receive ION283. The dose level of 15 mg will be studied in all subjects.
This description comes directly from the study's public registry record.
Kristy Riddle, RN, BSN · 214-456-9501 · LDRecruiting@utsouthwestern.edu
Ben Eckert, BA · LDRecruiting@utsouthwestern.edu
Always discuss trial participation with your own doctor first.
| Childrens Health | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06609889